Scholar Rock's drug for a rare neuromuscular disease
搜索文档
US FDA declines to approve Scholar Rock's muscle weakness drug
Reuters· 2025-09-23 19:12
The U.S. Food and Drug Administration has declined to approve Scholar Rock's drug for a rare neuromuscular disease, citing issues at a third party manufacturing facility, the company said on Tuesday. ...
